{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:39:19Z","timestamp":1786729159752,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-14230-5","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:54:21Z","timestamp":1786553661000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence of neonatal sepsis among HIV exposed neonates of mothers on integrase strand transfer inhibitors in sub-Saharan Africa: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Pebalo Francis","family":"Pebolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Bongomin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethan","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivaan","family":"Pitua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritah","family":"Nantale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venice","family":"Omona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ngonzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davidson H.","family":"Hamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"14230_CR1","unstructured":"United Nations Inter-agency Group for Child Mortality Estimation (UN IGME). Levels & Trends in child mortality: report 2023: estimates developed by the United Nations Inter-agency Group for Child Mortality Estimation. New York: United Nations Children\u2019s Fund; 2024."},{"key":"14230_CR2","doi-asserted-by":"crossref","unstructured":"Traor\u00e9 FB, Sidib\u00e9 CS, Diallo EHM, Camara BS, Sidib\u00e9 S, Diallo A, et al. Prevalence and factors associated with maternal and neonatal sepsis in sub-Saharan Africa: a systematic review and meta-analysis. Front Public Health. 2024;12.","DOI":"10.3389\/fpubh.2024.1272193"},{"issue":"8","key":"14230_CR3","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/archdischild-2020-320217","volume":"106","author":"C Fleischmann","year":"2021","unstructured":"Fleischmann C, Reichert F, Cassini A, Horner R, Harder T, Markwart R, et al. Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis. Arch Dis Child. 2021;106(8):745\u201352.","journal-title":"Arch Dis Child"},{"key":"14230_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fimmu.2016.00164","volume":"7","author":"AL Slogrove","year":"2016","unstructured":"Slogrove AL, Goetghebuer T, Cotton MF, Singer J, Bettinger JA. Pattern of infectious morbidity in HIV-exposed uninfected infants and children. Front Immunol. 2016;7:164.","journal-title":"Front Immunol"},{"issue":"9","key":"14230_CR5","doi-asserted-by":"publisher","first-page":"e054491","DOI":"10.1136\/bmjopen-2021-054491","volume":"12","author":"CM Bech","year":"2022","unstructured":"Bech CM, Stensgaard CN, Lund S, Holm-Hansen C, Brok JS, Nygaard U, et al. Risk factors for neonatal sepsis in Sub-Saharan Africa: a systematic review with meta-analysis. BMJ open. 2022;12(9):e054491.","journal-title":"BMJ open"},{"issue":"1","key":"14230_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/s12887-021-02969-6","volume":"21","author":"H Mellqvist","year":"2021","unstructured":"Mellqvist H, Saggers RT, Elfvin A, Hentz E, Ballot DE. The effects of exposure to HIV in neonates at a referral hospital in South Africa. BMC Pediatr. 2021;21(1):485.","journal-title":"BMC Pediatr"},{"key":"14230_CR7","unstructured":"World Health Organization. Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV. Geneva: World Health Organization; 2018. p. 1-82."},{"key":"14230_CR8","unstructured":"Centers for Disease Control and Prevention. Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission. Recommendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission in the United States. Washington (DC): US Department of Health and Human Services; 2025."},{"key":"14230_CR9","doi-asserted-by":"crossref","unstructured":"Caniglia EC, Shapiro R, Diseko M, Wylie BJ, Zera C, Davey S, et al. Weight gain during pregnancy among women initiating dolutegravir in Botswana. EClinicalMedicine. 2020;29-30:100615.","DOI":"10.1016\/j.eclinm.2020.100615"},{"issue":"1","key":"14230_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.7196\/SAMJ.2017.v107i1.12058","volume":"107","author":"W Venter","year":"2017","unstructured":"Venter W, Kaiser B, Pillay Y, Conradie F, Gomez G, Clayden P, et al. Cutting the cost of South African antiretroviral therapy using newer, safer drugs. SAMJ: South Afr Med J. 2017;107(1):28\u201330.","journal-title":"SAMJ: South Afr Med J"},{"issue":"14","key":"14230_CR11","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1177\/09564624221129410","volume":"33","author":"D Namara","year":"2022","unstructured":"Namara D, Schwartz JI, Tusubira AK, McFarland W, Birungi C, Semitala FC, et al. The risk of hyperglycemia associated with use of dolutegravir among adults living with HIV in Kampala, Uganda: A case-control study. Int J STD AIDS. 2022;33(14):1158\u201364.","journal-title":"Int J STD AIDS"},{"issue":"2","key":"14230_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/venereology3020008","volume":"3","author":"T Shimels","year":"2024","unstructured":"Shimels T, Bilal AI, Samuel D, Gedamu D, Solomon E, Shewamene Z. The Incidence of Type 2 Diabetes Mellitus and Weight Gain in People Living with HIV Receiving a Dolutegravir-Based Antiretroviral Therapy in Addis Ababa, Ethiopia: A Pilot Single-Arm Historical Cohort Study. Venereol [Internet]. 2024;3(2):96\u2013106. pp.].","journal-title":"Venereol [Internet]"},{"issue":"12","key":"14230_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11892-019-1267-6","volume":"19","author":"ME Bianco","year":"2019","unstructured":"Bianco ME, Josefson JL. Hyperglycemia During Pregnancy and Long-Term Offspring Outcomes. Curr Diab Rep. 2019;19(12):143.","journal-title":"Curr Diab Rep"},{"issue":"1","key":"14230_CR14","first-page":"15","volume":"22","author":"S Ahmad","year":"2012","unstructured":"Ahmad S, Khalid R. Blood glucose levels in neonatal sepsis and probable sepsis and its association with mortality. J Coll Physicians Surgeons\u2013Pakistan: JCPSP. 2012;22(1):15\u20138.","journal-title":"J Coll Physicians Surgeons\u2013Pakistan: JCPSP"},{"issue":"6","key":"14230_CR15","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/QAD.0000000000001755","volume":"32","author":"N Mulligan","year":"2018","unstructured":"Mulligan N, Best BM, Wang J, Capparelli EV, Stek A, Barr E, et al. Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV. Aids. 2018;32(6):729\u201337.","journal-title":"Aids"},{"issue":"6","key":"14230_CR16","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1128\/AAC.00173-15","volume":"59","author":"JB Pain","year":"2015","unstructured":"Pain JB, L\u00ea MP, Caseris M, Amiel C, Lassel L, Charpentier C, et al. Pharmacokinetics of Dolutegravir in a Premature Neonate after HIV Treatment Intensification during Pregnancy. Antimicrob Agents Chemother. 2015;59(6):3660\u20132.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"14230_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst reviews. 2015;4(1):1.","journal-title":"Syst reviews"},{"key":"14230_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jclinepi.2023.05.010","volume":"159","author":"HJ Sch\u00fcnemann","year":"2023","unstructured":"Sch\u00fcnemann HJ, Brennan S, Akl EA, Hultcrantz M, Alonso-Coello P, Xia J, et al. The development methods of official GRADE articles and requirements for claiming the use of GRADE - A statement by the GRADE guidance group. J Clin Epidemiol. 2023;159:79\u201384.","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"14230_CR19","doi-asserted-by":"publisher","first-page":"e804","DOI":"10.1016\/S2214-109X(18)30218-3","volume":"6","author":"R Zash","year":"2018","unstructured":"Zash R, Jacobson DL, Diseko M, Mayondi G, Mmalane M, Essex M, et al. Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study. Lancet Global Health. 2018;6(7):e804\u201310.","journal-title":"Lancet Global Health"},{"issue":"4","key":"14230_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","volume":"64","author":"H Balshem","year":"2011","unstructured":"Balshem H, Helfand M, Sch\u00fcnemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401\u20136.","journal-title":"J Clin Epidemiol"},{"issue":"10281","key":"14230_CR21","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S0140-6736(21)00314-7","volume":"397","author":"S Lockman","year":"2021","unstructured":"Lockman S, Brummel SS, Ziemba L, Stranix-Chibanda L, McCarthy K, Coletti A, et al. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010\/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 2021;397(10281):1276\u201392.","journal-title":"Lancet"},{"issue":"5","key":"14230_CR22","doi-asserted-by":"publisher","first-page":"e332","DOI":"10.1016\/S2352-3018(20)30050-3","volume":"7","author":"K Kintu","year":"2020","unstructured":"Kintu K, Malaba TR, Nakibuka J, Papamichael C, Colbers A, Byrne K, et al. Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial. lancet HIV. 2020;7(5):e332\u20139.","journal-title":"lancet HIV"},{"issue":"5","key":"14230_CR23","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1016\/S2352-3018(20)30038-2","volume":"7","author":"EC Jo\u00e3o","year":"2020","unstructured":"Jo\u00e3o EC, Morrison RL, Shapiro DE, Chakhtoura N, Gouv\u00e8a MIS, Teixeira MLB, et al. Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial. Lancet HIV. 2020;7(5):e322\u201331.","journal-title":"Lancet HIV"},{"issue":"10","key":"14230_CR24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.medcle.2020.01.014","volume":"155","author":"M Ill\u00e1n Ramos","year":"2020","unstructured":"Ill\u00e1n Ramos M, Mazariegos Orellana D, Prieto Tato LM, Navarro G\u00f3mez ML, Mu\u00f1oz G\u00e1lligo E, Ramos Amador JT. Effectiveness and safety of integrase inhibitors in HIV-infected pregnant women followed up in the Madrid Cohort. Med Cl\u00ednica (English Edition). 2020;155(10):441\u20134.","journal-title":"Med Cl\u00ednica (English Edition)"},{"issue":"10","key":"14230_CR25","doi-asserted-by":"publisher","first-page":"piaf076","DOI":"10.1093\/jpids\/piaf076","volume":"14","author":"CM McGann","year":"2025","unstructured":"McGann CM, Strysko J, Bayani O, Moorad B, Ntlhako N, Nwako N, et al. Effect of maternal HIV status on the early neonatal microbiome. J Pediatr Infect Dis Soc. 2025;14(10):piaf076.","journal-title":"J Pediatr Infect Dis Soc"},{"key":"14230_CR26","doi-asserted-by":"crossref","unstructured":"Powis KM, Shapiro RL. Protease inhibitors and adverse birth outcomes: Is progesterone the missing piece to the puzzle? Oxford University Press; 2015. pp. 4\u20137.","DOI":"10.1093\/infdis\/jiu397"},{"issue":"6","key":"14230_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1089\/aid.2022.0039","volume":"39","author":"M Failla","year":"2023","unstructured":"Failla M, Pasquali E, Galli L, Chiappini E. Integrase Strand Transfer Inhibitor Use in Children with Perinatal HIV-1 Infection: A Narrative Review. AIDS Res Hum Retroviruses. 2023;39(6):263\u201384.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"Suppl 3","key":"14230_CR28","first-page":"S187","volume":"11","author":"P Atuhaire","year":"2024","unstructured":"Atuhaire P, Kyohere M, Tusubira V, Davies HG, Musoke P, Sekikubo M, et al. HIV Exposure and Neonatal Sepsis: A Descriptive Etiological Study. Open Forum Infect Dis. 2024;11(Suppl 3):S187\u201392.","journal-title":"Open Forum Infect Dis"},{"key":"14230_CR29","doi-asserted-by":"crossref","unstructured":"Davies HG, Kyohere M, Tusubira V, Amone A, Wamawobe A, Komugisha C, et al. Etiology and antimicrobial resistance of culture-positive infections in Ugandan infants: a cohort study of 7000 neonates and infants. Open Forum Infect Dis. 2024.","DOI":"10.1093\/ofid\/ofae629"},{"issue":"2","key":"14230_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s15010-019-01384-5","volume":"48","author":"M Floridia","year":"2020","unstructured":"Floridia M, Dalzero S, Giacomet V, Tamburrini E, Masuelli G, Savasi V, et al. Pregnancy and neonatal outcomes in women with HIV-1 exposed to integrase inhibitors, protease inhibitors and non-nucleoside reverse transcriptase inhibitors: an observational study. Infection. 2020;48(2):249\u201358.","journal-title":"Infection"},{"issue":"4","key":"14230_CR31","doi-asserted-by":"publisher","first-page":"F391","DOI":"10.1136\/archdischild-2017-313595","volume":"103","author":"A Collins","year":"2018","unstructured":"Collins A, Weitkamp J-H, Wynn JL. Why are preterm newborns at increased risk of infection? Archives Disease childhood-fetal neonatal Ed. 2018;103(4):F391\u20134.","journal-title":"Archives Disease childhood-fetal neonatal Ed"},{"issue":"41","key":"14230_CR32","doi-asserted-by":"publisher","first-page":"15137","DOI":"10.1074\/jbc.REV119.006901","volume":"294","author":"AN Engelman","year":"2019","unstructured":"Engelman AN. Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition. J Biol Chem. 2019;294(41):15137\u201357.","journal-title":"J Biol Chem"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14230-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14230-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14230-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:02:16Z","timestamp":1786726936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-14230-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14230"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14230-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"15 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This systematic review and meta-analysis utilized data from publicly available published studies; therefore, ethical approval was not required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1496"}}